INCY Dividend History & Analysis | N/A Yield
INCY has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| BTX | 1,406 M | 13.4% | 7.37% |
| ABBV | 403,830 M | 3.77% | 9.44% |
| AMGN | 176,250 M | 3.75% | 6.02% |
| GILD | 150,882 M | 2.67% | 6.12% |
| HLN | 44,530 M | 1.74% | 2.46% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BTX | 1,406 M | 134% | 95.6% |
| HLN | 44,530 M | 30.1% | 100% |
| AMGN | 176,250 M | 7.84% | 100% |
| ABBV | 403,830 M | 5.98% | 100% |
| GILD | 150,882 M | 2.71% | 100% |
Similar Stocks with Attractive Dividends - Compare INCY Dividends with its Peer-Group
3.75% Yield
3.77% Yield
2.67% Yield
1.74% Yield
INCY Dividend History: as of January 2026
No dividends paid yet.INCY Dividend FAQ
Incyte Corporation (NASDAQ: INCY) is a U.S.-based biopharmaceutical firm that discovers, develops, and commercializes specialty therapeutics across the United States, Europe, Canada, and Japan. Its marketed portfolio includes JAKAFI (ruxolitinib) for myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI/MINJUVI (tafasitamab) for relapsed/refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib) for biliary-tract cancers and cholangiocarcinoma; ICLUSIG (ponatinib) for chronic myeloid leukemia and Ph+ ALL; ZYNYZ (retifanlimab) for Merkel cell carcinoma; NIKTIMVO (axatilimab) for chronic GVHD; and OPZELURA (ruxolitinib) cream for atopic dermatitis.
What is the Dividend Yield of INCY?
As of January 2026, INCY`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 106.66.Does INCY pay a dividend?
As of January 2026 INCY does not pay a dividend.How often does INCY pay dividends?
Over the last 12 months, INCY has issued dividend payments.INCY dividend forecast
Based on historical data, the forecasted dividends per share for INCY for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will INCY pay dividends in 2026?
The next Ex-Dividend date for Incyte (INCY) is currently unknown.What is the next Ex-Dividend Date for INCY?
The next Ex-Dividend date for Incyte (INCY) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of INCY?
INCY's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of INCY?
INCY's 5-Year Yield on Cost is -%. If you bought INCY's shares at 93.83 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of INCY?
INCY Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does INCY have a good Dividend Yield?
INCY`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of INCY?
The Dividend Payout Ratio of INCY is unknown.What is the Dividend Rating of INCY?
INCY`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2026-01-05 02:16